PRIG
LLY icon

Payden & Rygel Investment Group’s Eli Lilly LLY Stock Holding History

Payden & Rygel Investment Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$21.9M Sell
24,220
-2,300
-9% -$1.84M 1.77% 12
2024
Q1 		$20.6M Buy
+26,520
New +$18.9M 0.97% 26
2023
Q3 		$16.1M Buy
+29,920
New +$15.4M 1.1% 30

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Payden & Rygel Investment Group's LLY Position: Q2 2024 in Review

Payden & Rygel Investment Group reduced its Eli Lilly (LLY) stake by 8.7% in Q2 2024, selling an estimated $1.84M and leaving 24,220 shares worth $21.9M. The position accounts for 1.77% of the portfolio, ranked #12.

Payden & Rygel Investment Group first reported a position in LLY in Q3 2023 and has held it in 3 quarters since. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Payden & Rygel Investment Group held 24,220 shares of Eli Lilly worth $21.9M as of Q2 2024.
  • Payden & Rygel Investment Group sold 2,300 Eli Lilly shares in Q2 2024, an estimated $1.84M.
  • Eli Lilly made up 1.77% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #12 holding.
  • Payden & Rygel Investment Group first reported a position in Eli Lilly in Q3 2023 and has held it in 3 quarters since.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.